联系客服

600535 沪市 天士力


首页 公告 600535:天士力关于公司2019年度主要经营数据的公告

600535:天士力关于公司2019年度主要经营数据的公告

公告日期:2020-04-25

600535:天士力关于公司2019年度主要经营数据的公告 PDF查看PDF原文

              证券代码:600535        证券简称:天士力        编号:临 2020-033 号

                          天士力医药集团股份有限公司

                      关于公司 2019 年度主要经营数据的公告

                  本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导

              性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及

              连带责任

                根据上海证券交易所发布的上市公司分行业信息披露指引《上市公司行业信息披

            露指引第七号——医药制造》及《关于做好上市公司 2019 年度报告披露工作的通知》

            相关要求,现将公司 2019 年度主要经营数据披露如下:

                一、报告期内分行业经营数据

                                                            单位:元币种:人民币

                      主营业务收入                                  主营业务成本                      毛利率(%)

行业                                          增长率                                          增长  本期  上年  增长
          本期累计        上年同期累计    (%)      本期累计        上年同期累计    率(%) 累计  同期    率
                                                                                                            累计

医药  6,215,424,195.30  7,126,736,492.49  -12.79  1,576,836,226.53  1,744,187,940.93  -9.59  74.63  75.53  -0.90
工业

医药  12,717,059,105.85  10,778,337,519.74    17.99  11,443,187,225.46  9,696,833,600.86  18.01  10.02  10.03  -0.02
商业

合计  18,932,483,301.15  17,905,074,012.23    5.74  13,020,023,451.99  11,441,021,541.79  13.80  31.23  36.10  -4.87

                                                          单位:元  币种:人民币

        分治疗领域        营业收入            营业成本      毛利率(%)  营业收入比上  营业成本比上  毛利率比上

                                                                            年增减(%)    年增减(%)  年增减(%)

        心脑血管        4,257,741,238.85  1,057,166,743.26      75.17        -14.28          -5.90      -2.21

          抗肿瘤          944,188,163.59    171,796,922.02      81.80          18.25          -8.10        5.22

        感冒发烧          175,526,284.28      87,278,773.21      50.28        -56.91        -47.93      -8.57


 分治疗领域        营业收入            营业成本      毛利率(%)  营业收入比上  营业成本比上  毛利率比上
                                                                    年增减(%)    年增减(%)  年增减(%)

肝病治疗          334,562,107.47      76,628,738.41      77.10        -22.71        -16.35      -1.74

    其他            503,406,401.11    183,965,049.63      63.46          -3.37          5.35      -3.03

医药工业小计      6,215,424,195.30  1,576,836,226.53      74.63        -12.79          -9.59      -0.90

医药商业小计    12,717,059,105.85  11,443,187,225.46      10.02          17.99          18.01      -0.02

    合计        18,932,483,301.15  13,020,023,451.99      31.23          5.74          13.80      -4.87

                                                      单位:元币种:人民币

    分产品        营业收入          营业成本      毛利率    营业收入比    营业成本比  毛利率比上年

                                                        (%)  上年增减(%) 上年增减(%)  增减(%)

      中药      4,348,326,449.29  1,159,414,312.38    73.34        -18.85        -11.23          -2.29

  化学制剂药    1,606,254,340.31    316,890,045.19    80.27          7.08        -8.71          3.41

  化学原料药      44,217,582.70      23,570,032.66    46.70          8.74        -3.18          6.56

    生物药        216,625,823.00      76,961,836.30    64.47        -4.83        15.43          -6.24

  医药工业小    6,215,424,195.30  1,576,836,226.53    74.63        -12.79        -9.59          -0.90

      计

  医药商业小  12,717,059,105.85  11,443,187,225.46    10.02        17.99        18.01          -0.02

      计

      合计      18,932,483,301.15  13,020,023,451.99    31.23          5.74        13.80          -4.87

          报告期内,公司感冒发烧产品收入较上年同期降低 56.91%,主要系穿心莲、柴
      胡、藿香销售下降所致。

          二、报告期内分地区经营数据

                                                      单位:元币种:人民币

        地区          本期累计主营业务收入    上年同期累计主营业务收入  增长比例(%)

        天津市              10,715,049,685.53          12,343,272,775.78          -13.19

        北京市                779,376,940.26              913,256,092.80          -14.66

        广东省              1,189,541,886.91            1,013,881,262.88          17.33

        山东省                463,283,597.03              522,685,563.49          -11.36

        陕西省              5,089,768,936.97            4,278,763,268.72          18.95


 地区          本期累计主营业务收入    上年同期累计主营业务收入  增长比例(%)

湖南省              1,146,331,472.58            1,052,049,327.67            8.96

辽宁省              2,730,648,691.23            2,551,884,601.67            7.01

江苏省              1,363,129,401.67            1,192,499,379.25          14.31

河南省                  96,644,591.86              123,169,378.81          -21.54

上海市                218,975,370.60              230,104,638.80          -4.84

山西省              1,648,468,974.38            1,073,147,638.62          53.61

 其他                  192,104,722.53              114,201,802.19          68.22

 小计              25,633,324,271.55          25,408,915,730.68            0.88

 抵消                6,700,840,970.40            7,503,841,718.45          -10.70

 合并            
[点击查看PDF原文]